IRIDEX Corporation (IRIX)
NASDAQ: IRIX · Real-Time Price · USD
1.220
-0.080 (-6.15%)
Apr 29, 2025, 11:55 AM EDT - Market open
IRIDEX Employees
IRIDEX had 93 employees as of December 28, 2024. The number of employees decreased by 18 or -16.22% compared to the previous year.
Employees
93
Change (1Y)
-18
Growth (1Y)
-16.22%
Revenue / Employee
$523,323
Profits / Employee
-$95,806
Market Cap
20.48M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
IRIX News
- 12 days ago - IRIDEX Corporation (IRIX) Strategic Vision Conference Call (Transcript) - Seeking Alpha
- 19 days ago - Iridex to Host Strategic Vision Call on April 16, 2025 - GlobeNewsWire
- 4 weeks ago - IRIDEX Corporation (IRIX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Iridex Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 5 weeks ago - Iridex Announces Strategic Investment in the Company - GlobeNewsWire
- 6 weeks ago - Iridex Comments on Recent Stock Price Volatility - GlobeNewsWire
- 6 weeks ago - Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025 - GlobeNewsWire
- 4 months ago - Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management - GlobeNewsWire